Ongoing

Biomedical Translation Fund

Funding

Up to $500,000,000

Region

Commonwealth

View Official Page

Overview

The Biomedical Translation Fund provides capital to support groundbreaking innovation in Australia, helping commercialize research from universities and research organizations into commercial products. The fund pools $500 million in total capital ($250 million from the federal government and $250 million from private investors) to support venture capital managers in taking Australian biomedical innovations through the commercial pathway.

Eligibility Requirements

Supports innovative biomedical companies and technologies, particularly those commercializing research from universities and research organizations that need capital to scale and move from research to commercial product development.

Who Can Apply

Startups

Relevant Industries

HealthBiomedicalTechnology

How to Apply

Applications are submitted through the official government portal. Review the eligibility criteria carefully before applying, and ensure all supporting documents are prepared.

Visit the official application page

Disclaimer: Grant information is sourced from official government websites and updated regularly. Always verify current eligibility and deadlines on the official program page before applying.

Related Grants

Ongoing·Commonwealth

Early Stage Venture Capital Limited Partnerships (ESVCLPs)

A venture capital program that provides capital and professional expertise to innovative Australian early-stage companies and high-growth startups. The program offers increased fund sizes up to $200 million, a 10% tax offset on capital deployed into start-up companies, and a tax-exempt environment for investment returns.

Ongoing·Commonwealth·$800,000 - $19,200,000

Blood Borne Viruses (BBV) and Sexually Transmissible Infections (STI) Research Program

This grant program is delivered, in part, through the collection of data, ongoing surveillance, and pertinent research and evaluation activities related to the BBV and STI outlined in the National BBV and STI Strategies, namely: National Hepatitis B Strategy National Hepatitis C Strategy National STI Strategy National Aboriginal and Torres Strait Islander BBV and STI Strategy National HIV Strategy. The Department’s First National BBV and STI Research Strategy 2021-2025 and its future iterations (the National BBV and STI Research Strategy), sets out the aims and objectives for the multi-disciplinary research activities undertaken within Australia and supports the implementation of the related National BBV and STI Strategies. By enabling and focussing on the conduct of BBV and STI research, the Research Strategy aims to identify challenges, barriers and opportunities to achieve the agreed national goals and targets of the National BBV and STI Strategies. The Research Strategy also contai

Open·Commonwealth·$5,000,000 - $20,000,000

MRFF - EPCDRI - 2025 Childhood Mental Health Research Grant Opportunity

The Medical Research Future Fund (MRFF) Emerging Priorities and Consumer-Driven Research initiative aims to enable or support research that improves patient care and translation of new discoveries, and encourage collaboration between consumers and researchers. Funding from this Initiative will support the development of new diagnoses, treatments and cures, and the translation of new discoveries into clinical practice. Three topics of funding are available based on the primary focus of the research or the geographic location of the organisation undertaking the majority of the research. The objective of this grant opportunity is to: Topic A (Aim 2 of Research Plan; TCR): improving the mental health of First Nations children through research led by First Nations researchers that includes meaningful involvement of First Nations communities. Topic B (Aim 2 of Research Plan; TCR): the organisation undertaking the majority of the research is based in any area according to the Modified Monash